*This is not financial advice, so trade at your own risks*
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management*
Mirum Pharmaceuticals:
My team has been reviewing Mirum Pharmaceuticals for close to two months, and despite its poor performance in the past month it remains one of top picks for the month of June.
MIRM is to release data collected on maralixibat on 6/5/21.
Tomorrow morning we are averaging up on our positions at $17.00. Our original entry was at $16.30.
Short term take profit @$20.00 Long Term take profit $26.00
If you want to see more, please like and follow us @SimplyShowMeTheMoney
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management*
Mirum Pharmaceuticals:
My team has been reviewing Mirum Pharmaceuticals for close to two months, and despite its poor performance in the past month it remains one of top picks for the month of June.
MIRM is to release data collected on maralixibat on 6/5/21. Tomorrow morning we are averaging up on our positions at $17.00. Our original entry was at $16.30.
Short term take profit @$20.00 Long Term take profit $26.00
If you want to see more, please like and follow us @SimplyShowMeTheMoney
関連の投稿
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。